100% SATISFACTION PROMISE + FREE DELIVERY



What physician's need to know about Type 2 Diabetes Drug classes that effect heart disease

Posted by Daniel Patrick on

The American Journal of Medicine, Volume 132, Issue 9, 1027 - 1031

The 2019 American Diabetes Association guidelines have recommended considering atherosclerotic cardiovascular disease risk when deciding on additional antihyperglycemic agents following metformin and lifestyle changes, with a preference for GLP-1 RA or SGLT2 agents for patients with cardiovascular disease.32 Both the safety profile and important cardiovascular benefits of novel therapeutic developments thus far suggest that these drug classes will continue to grow as important options for clinicians going forward.The 2019  American Diabetes Association Guidelines recommend considering atherosclerotic cardiovascular disease risk when deciding on additional antihyperglycemic agents following metfromin and lifestyle changes, with  Two newer classes of drug used to manage Type 2 Diabetes are  patients with high cardiovascular risk GLP-1 RAs 

Reference:

  1. What Clinicians Need to Know About the Cardiovascular Effects of the Most Recent Classes of Drugs Used for Type 2 Diabetes

    Ferraro, Richard A. et al.
    The American Journal of Medicine, Volume 132, Issue 9, 1027 - 1031

https://www.amjmed.com/article/S0002-9343(19)30250-5/fulltext#s0015

0 comments

Leave a comment

Please note, comments must be approved before they are published